Neurotransmitter receptor proteins are critical to learning and memory. Mutations are associated with many neurological and neuropsychiatric conditions including Alzheimer's, epilepsy, and autism. Multiple structures of two such receptors, solved by x-ray crystallography at the ALS, provide a blueprint for the development of potential therapeutics.